Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc is well-positioned within the lucrative COVID-19 vaccine market, which generated approximately $56 billion in revenue in 2022, with its antibody candidates promising enhanced protection against viral diseases. The company has secured FDA approval for its Phase 3 REVOLUTION program, which, if successful, could significantly expand the market opportunity for its monoclonal antibody candidate VYD2311, potentially establishing its superiority over existing mRNA vaccines. Additionally, VYD2311's incorporation of half-life extension technology suggests a best-in-class potential that could contribute to a projected market growth to $3-4 billion globally by 2030, highlighting a favorable outlook for Invivyd's financial future.

Bears say

Invivyd Inc faces a negative outlook primarily due to the disappointing results from the STAMP trial, which revealed a 200-fold decrease in activity of its antibody candidates against the omicron variant, undermining earlier optimistic projections. Additionally, the company's potential market has been further constricted as vaccination rates for COVID-19 and influenza continue to decline, particularly among vulnerable populations such as the elderly and immunocompromised, who would require robust protection. These factors contribute to an overall diminished commercial opportunity, significantly impacting the company's financial prospects and viability in the competitive landscape of infectious disease therapeutics.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.